Furthermore, in our previous studies, we have shown that circulating S1P is able to amplify lung cancer-associated inflammatory processes through the interaction of S1P with S1PR3 both in circulating peripheral blood mononuclear cells (PBMCs) [32] and in lung cancer epithelial cells [19]. This evidence concerns the gene S1PR3 and lung carcinoma.